Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Decoding Cannabis: what a recent scoping review reveals about cannabis for rheumatoid arthritis
A recent scoping review has dug into how cannabinoids interact with inflammation, joint tissue, and pain signalling in rheumatoid arthritis. This article breaks down what the researchers found, how THC and CBD influence key inflammatory pathways, and what these insights may mean for people living with arthritis in the UK. We also look at how this evidence compares with current patient experiences.
Unlocking rights: Key housing guidance for medical cannabis patients
Medical cannabis may have been legal in the UK since 2018, but many patients have been left feeling confused about their rights when it comes to taking their medication - both in public and the comfort of their own homes. Recently, the Cannabis Industry Council published further, much-needed guidance regarding medical cannabis and housing.
Exploring different diets for different health conditions
Diet has been linked to a huge number of health conditions, many of which represent a significant risk of morbidity. Yet, while many of us may make a conscious effort to eat a relatively healthy diet, we may overlook how different diets can benefit or exacerbate certain existing health conditions.
Releaf medical cannabis: why a varied formulary is essential
Every patient is unique, and so are their medical needs. As a medical cannabis clinic, having a varied formulary allows us to cater to a large cohort of patients, from those with chronic pain or insomnia, to those with anxiety and depression, or MS and Parkinson’s, and offer them each unique, individualised treatment plans.
NHS investment in cannabis-based research
Medical cannabis was legalised in the UK in 2018 following high-profile campaigns by patients and advocates, primarily concerning the use of cannabis-based medicines in the treatment of refractory epilepsy. Over six years on, only a handful of patients have received an NHS prescription for medical cannabis. But could the completion of long-awaited NHS-backed medical cannabis clinical trials help improve access to these medicines in the future?